| |
|
|
Programme
The see the full agenda and speaker line up click here for the brochure.
Day One | Day
Two
| May 26th |
May 27th |
| Start: 09:00 |
Start: 09:00 |
| Finish: 17:45 |
Finish: 16:50 |
| Networking Party: 17:45 – 19:15 |
|
Expand All Overviews | Collapse All Overviews
Day 1: May 26
Theme 1 (Day 1): Maximize the product value by creating effective marketing strategy that matches market needs
| Section 1: Reviewing your current marketing strategies |
9:00-9:35 Patient Focus Commercial Operation
Renaud Gabay, Marketing Director, Abbott Japan Co., Ltd.
Click here to read the session overview |
- How to build Continuous Medical Education Programs and Communication for Doctors that are oriented to address Drs. and Patients unmet need?
- Scientific/Medical support as a key role: How to upgrade our knowledge of market needs and our ability to answer them?
- How do we move from traditional Product Centered Message to truly Patient Focus Communication Organization?
Renaud Gabay, Marketing Director, Abbott Japan Co., Ltd. |
|
9:35-10:10 Strategic Planning with Insight: How to leverage your Marketing Excellence Program
Gabrielle Pastore, Managed Markets Brand Director, AstraZeneca KK
Click here to read the session overview |
- Marketing Excellence: who owns it, who is on the team and what is the remit?
- A "new" annual strategic planning process
- The importance of gaining appropriate Insight (and challenges in Japan)
- Identification of Barriers and developing specific plans to address each one  Â
Gabrielle Pastore, Managed Markets Brand Director, AstraZeneca KK |
|
10:10-10:45 Coping with the information avalanche and physician/patient communication in the new era of personalized medicine in oncology
Shinya Chimoto, Group Manager, Syndicated Research Services Division, Synovate Healthcare
Click here to read the session overview |
During the past several years cancer treatment has begun to change quite radically with the introduction of advanced technologies and treatments such as targeted therapy drugs, companion diagnostics, high resolution imaging, and other elements of personalized medicine.
- How are physicians themselves coping in keeping up with the avalanche of new knowledge, and how are they handling communication of these developments with patients?
- How well do patients understand the explanations they are receiving from physicians?
The presentation will provide information from a study conducted among some 2,000 cancer treating physicians as well as from a separate patient survey.
Shinya Chimoto, Group Manager, Syndicated Research Services Division, Synovate Healthcare |
| 10:45 - 11:15 Coffee Break |
11:15 - 11:50 How to create effective marketing strategies for Generics that match your clients’ needs?
Yuji Umeki, General Manager, Generics Marketing Dept., Meiji Seika Kaisha Ltd.
Click here to read the session overview |
- How to find out formula that adds a value to your generics to meet medical needs?
- Learn how to create reliable Medical Reps (MRs) activities for your clients by suggesting a wide range of treatment plan for both new medicine and generics
Yuji Umeki, General Manager, Generics Marketing Dept., Meiji Seika Kaisha Ltd.
|
|
| Section 2: Market Analysis to maximize marketing effectiveness |
11:50 - 12:25 Key Performance Indicators (KPIs): How to set up more precise KPI measurement for improving sales & marketing performance
Kenneth A. Shearer, Director, Business Intelligence & Research, Customer & Commercial Excellence Division, Banyu Pharmaceutical Co., Ltd.
Click here to read the session overview |
- Key Performance indicators: Which ones will drive more sales and increase the effectiveness of your marketing campaigns?
- Learn how to set up the precise measurement that is suitable for your company
- Discover how to increase the performance of your sales & marketing and how to measure this in Japan?
Kenneth A. Shearer, Director, Business Intelligence & Research, Customer & Commercial Excellence Division, Banyu Pharmaceutical Co., Ltd. |
| 12:25 - 13:25 Lunch |
13:25 - 14:00 Building Forecasting Capabilities in the Global Context
Eric Persoff, Manager, ZS Associates
Hiroshi Yamamoto, Associate Principal, Tokyo Office, ZS Associates Click here to read the session overview |
- Discover what aspects of forecasting methodologies commonly in use in the pharmaceutical industry can be generalized across regions and geographies, and what aspects must be customized for the specific country of interest.
- Expert suggestions for competitive dynamics and generic erosion, physician and patient response to product promotion, and access, reimbursement, and government regulation.
Eric Persoff, Manager, ZS Associates
Hiroshi Yamamoto, Associate Principal, Tokyo Office, ZS Associates |
|
14:00 - 14:35 Maximize effectiveness of your sales and marketing by meeting doctors’ and patients’ needs for effective medical communication
Noboru Sugiyama, Senior Director, Strategic Alliance Group and Partner Solutions Group Enterprise Partner Sales Group, Microsoft Co.,Ltd.
Hitoshi Hara, Director, IN3 Division, IUK Inc. Click here to read the session overview |
- Build better relationships with doctors and patients, by providing them with advanced information search technology.
- Make the best use of your information sources through an effective information management system.
Noboru Sugiyama, Senior Director, Strategic Alliance Group and Partner Solutions Group Enterprise Partner Sales Group,
Microsoft Co.,Ltd.
Hitoshi Hara, Director, IN3 Division, IUK Inc. |
|
14:35 - 15:10 The reality of market research: what company is doing better than others?
Tetsuya Kajiwara, Representative, Pharma Meeting
Senior Manager, Marketing Research, Business Operataion, Schering-Plough K.K. Click here to read the session overview |
- Find out the reality of market research (based questionnaire from 30 “Pharma Meeting”data *)
- What kind of research other pharma companies are conducting for their products’lifecycle?
- Where market research stand on creating strategies?
Tetsuya Kajiwara, Representative, Pharma Meeting
Senior Manager, Marketing Research, Business Operataion, Schering-Plough K.K. |
|
15:10 - 15:45 Epidemiology and Pharmaceutical Market Assessment in Japan: Keys to Success
Victor Shrenzel, President, Synix Inc.
Click here to read the session overview |
Based on Synix’s 12 years of experience in assisting pharmaceutical companies in Japan with epidemiology, this presentation will provide an overview of topics such as:
- How do pharmaceutical companies utilize epidemiology data in Japan? Epidemiology data sources in Japan – what pharmaceutical companies find useful and reliable?Strengths and weaknesses of epidemiological analyses in Japan?Using epidemiology to help define commercially relevant patient segments
- Challenges by disease types
Victor Shrenzel, President, Synix Inc. |
15:45 - 16:15 Coffee Break |
16:15 - 17:45 Workshop: A Step-by-Step Process to Forecasting in the Japanese Pharmaceutical Market
Eric Persoff, Manager, ZS Associates
Hiroshi Yamamoto, Associate Principal, Tokyo Office, ZS Associates
Click here to read the session overview |
The workshop will walk attendees through the process of developing forecasts in Japan. The workshop will consider two different situations: a late stage development product on the verge of launch, and a mature in-market product. For each situation, issues covered will include selection of the appropriate forecasting methodology, identification of data sources to fill forecast assumptions, and how to use judgment to fill data gaps. The workshop will expand on the issues covered in the presentation and will discuss what aspects of the issues are unique and specific to Japan. The workshop will begin with a general overview of ZS's outlook on forecasting and will then provide attendees with the opportunity for hands-on experience in constructing a forecast for the Japanese market.
Eric Persoff, Manager, ZS Associates
Hiroshi Yamamoto, Associate Principal, Tokyo Office, ZS Associates |
| 17:45 - 19:15 Networking Party |
Day One | Day
Two
Back to top
Day 2 – May 27th
Theme 2 (Day 2): Market survival depends on achieving Patient-Centered marketing strategies
| Section 3: Understand patient-centric strategies |
9:00 - 9:35 How to implement patients’ needs into your marketing actions
Neil Aubuchon, Senior Director, Marketing, Eli Lilly Japan K.K.
Click here to read the session overview |
- How to find out patients’ true needs: Is it possible to distinguish their needs by their disease type?
- Learn how to identify patient’s preference for specific medicines to improve patient compliance
- Hear how you can integrate patients’ needs with phase of creating strategies for various marketing campaigns
Neil Aubuchon, Senior Director, Marketing, Eli Lilly Japan K.K. |
|
9:35 - 10:10 Patient-centric marketing in Japan: A real life experience
Brent McCain, Head, Marketing Excellence, sanofi-aventis K.K.
Click here to read the session overview |
- How to drive changes from product-centric to patient-centric marketing
- Direct to consumer (patients) marketing: What works best and when
- Where patient-centric marketing is heading towards
Brent McCain, Head, Marketing Excellence, sanofi-aventis K.K. |
|
10:10 - 10:45
How to better co-operate with pharmacies: an example of the home care service approach
Keiji Arai, Representative Director & President, Sugi Medical Co.,Ltd
Click here to read the session overview |
- Learn what kind of services home care services are currently providing to patients
- Hear what sort of information and services home care services and patients are looking for
- How to collaborate better with pharmacies and where exactly pharma marketing can improve the communication for them
Keiji Arai, Representative Director & President, Sugi Medical Co.,Ltd |
10:45 - 11:15 Coffee Break |
11:15 - 11:50 Understand needs of patient advocacy groups: What are they looking for in pharma marketing communication?
Miho Katagi, President, Ovarian Cancer Support Group SMILEY
Click here to read the session overview |
- Understand how patient advocacy group operate to meet patients’ needs
- Find out patient advocacy group’s views on ideal collaboration methods with  pharma companies
- Ways to create better co-operation between pharma and patient advocacy groups near future
Miho Katagi, President, Ovarian Cancer Support Group SMILEY |
|
11:50 - 12:50 Panel Discussion 1: How to actually implement patient-centric strategies in your marketing
Neil Aubuchon, Senior Director Marketing, Eli Lilly Japan K.K.
Kees Roks, Head Marketing Division General Medicine, Novartis Pharma K.K.
Renaud Gabay, Marketing Director, Abbott Japan Co., Ltd.
Miho Katagi, President, Ovarian Cancer Support Group SMILEY
Keiji Arai, Representative Director & President, Sugi Medical Co.,Ltd
Click here to read the session overview |
- How to put patients at the center of decision makings before creating marketing strategies?
- Discuss how to create a shift in your company’s business model from product-centred to focus on developing new products that consumers (patients) are truly looking for?Â
- How to encourage more collaborative relationships between patients, doctors, pharmacies and pharma?
- Understand what kind of information and communications patients are hoping for pharma companies to provide?
- What kind of plan and program pharma companies need to create in order to achieve marketing activities that match with patients’ point of view?
Panellists:
Neil Aubuchon, Senior Director Marketing, Eli Lilly Japan K.K.
Kees Roks, Head Marketing Division General Medicine, Novartis Pharma K.K.
Renaud Gabay, Marketing Director, Abbott Japan Co., Ltd.
Miho Katagi, President, Ovarian Cancer Support Group SMILEY
Keiji Arai, Representative Director & President, Sugi Medical Co.,Ltd |
|
| 12:50 -13:50 Lunch |
| Section 4: Branding and Loyalty |
13:50 - 14:25 Lean from the successful branding strategies of Unilever - case study of men's fragrance AXE (known as Lynx in some western countries)
Seikei Ito , Communications Director,
Unilever Japan Holdings K.K
Click here to read the session overview |
- Hear the secret of how AXE has achieved global success and increased their Japanese market share to 200% in the first year of the launch
- Learn how to create effective branding strategies, including communication and activation from launch to in-line marketing
- How to fully utilize global best practice while developing the products that match with Japanese consumers’ needs.
- How to successfully set up different communication methods at each stage of the promotion.
Seikei Ito, Communications Director, Unilever Japan Holdings K.K |
|
| Section 5: Utilizing DTC marketing and website to improve patient-focused strategies |
14:25 - 15:00 Evaluating Direct to Consumer Initiatives as an effective contributor to brand growth
Hans Nagl, Director, Promotion Response Insight, Shire Ltd.
Click here to read the session overview |
- Gain knowledge of different approaches to measuring Direct to Consumer campaigns in various markets and countries
- Find out when and how Direct to Consumer campaigns could help grow your brand
- Learn about different types of DTC campaigns and their impact on Rx growth
Hans Nagl, Director, Promotion Response Insight, Shire Ltd. |
|
15:00 - 15:35 How user-focused e-detail should be?
Hiroshi Kaihatsu, Manager, Planning Section Business Strategy & Planning Department, Japan Business Headquarters, Eisai Co.,Ltd
Click here to read the session overview |
- Re-think of pharma websites: Are they really necessary?
- Learn how to utilize persona to create user-friendly websites
- How to shift all tasks to patient-focused concepts
Hiroshi Kaihatsu, Manager, Planning Section Business Strategy & Planning Department,
Japan Business Headquarters, Eisai Co.,Ltd |
|
| Section 6: Web 2.0: Risks & Benefits for Pharma Industry to engage with patients in the digital world - The Japanese Perspective |
15:35 - 16:50 Panel Discussion 2:
Understanding the environment created by the new Internet generation and its impact on healthcare in Japan
Philippe Auvaro, VP, Commercial Administration & Planning, GlaxoSmithKline Japan
Shigekazu Kawai, Manager, Customer Relations Department, Commercial Administration & Planning,GlaxoSmithKline K.K.
Mark Bard, President, Manhattan Research
Yasushi Goto, Medical Staff,
Department of Respiratory Medicine,Graduate School of Medicine, University of Tokyo
Akihiro Yanagisawa,
Secretary General,
CancerNet Japan, NPO
Click here to read the session overview |
- Presentation of core statistics demonstrating a shift in Japanese public usage and awareness of health & medical services on Internet
- Which information, which services to serve the patient and the community best? A review of concrete practices, and debate about future perspectives
- Communicating with the digital world; is there a role for pharma in the blogsphere? Is it a source of insight for marketing strategy?
- The debate of social media regulations in US FDA - perspectives and lessons for Japan
Panellists:
Philippe Auvaro, VP, Commercial Administration & Planning, GlaxoSmithKline Japan
Shigekazu Kawai, Manager, Customer Relations Department, Commercial Administration & Planning,GlaxoSmithKline K.K.
Mark Bard, President, Manhattan Research
Yasushi Goto, Medical Staff,
Department of Respiratory Medicine,Graduate School of Medicine, University of Tokyo
Akihiro Yanagisawa, Secretary General, CancerNet Japan, NPO |
| End of the summit |
Day One | Day
Two
Back to top |
|